SET Announcements | Interpharma Group (IP)

Report on the results of the Exercise of IP-W2 (F53-5) (Revised)

Report on the results of the Exercise of IP-W2 (F53-5)

27 May 2025 is the last trading day of IP-W2

Management Discussion and Analysis Quarter 1 Ending 31 Mar 2025

Financial Performance Quarter 1 (F45) (Reviewed)

Financial Statement Quarter 1/2025 (Reviewed)

Publication of the Minute of the 2025 Annual General Meeting of Shareholders on the Company's Website

Shareholders meeting's resolution

Trading Suspension and termination of listing status of IP-W2

Notification the final exercise and request for suspension of IP-W2

Signing of Exclusive Distribution Agreement with Zhaoke Ophthalmology Company Limited for Comprehensive Eye Care Innovation

Publication of the Invitation to the 2025 Annual General Meeting of Shareholders and the 56-1 One Report 2024 on the Company's Website